Concepedia

Author

Barna Budai

National Institute of OncologyORCID

Also Known As

B Budai, B. Budai, B.C. Budai, Balázs Budai, Barna Budai, Bianka Budai

77

Publications

1.1K

Citations

17

H-Index

40

Concepts

All Affiliations

National Institute of OncologySemmelweis UniversityEötvös Loránd UniversitySzent János Kórház
BB

About

Barna Budai is an author at National Institute of Oncology specializing in medicine, radiation oncology, and oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

10

10

249

2

Engineering

2

2

41

3

Biochemistry

1

1

18

4

Biomedical Engineering

1

1

22

5

Endocrinology

1

1

10

Barna Budai

×

20

Publications

548

Citations

15

H-Index

YearCitations

Cetuximab and platinum-based chemoradio- or chemotherapy of patients with epidermal growth factor receptor expressing adenoid cystic carcinoma: a phase II trial

Erika Hitre, Barna Budai, Zoltán Takácsi‐Nagy,

British Journal of Cancer

2013

70

Influence of thymidylate synthase gene polymorphisms on the survival of colorectal cancer patients receiving adjuvant 5-fluorouracil

Erika Hitre, Barna Budai, Vilmos Adleff,

Pharmacogenetics and Genomics

2005

69

SHMT1 1420 and MTHFR 677 variants are associated with rectal but not colon cancer

Viktor Komlósi, Erika Hitre, Éva Pap,

BMC Cancer

2010

48

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study

Gábor Rubovszky, István Láng, Erna Ganofszky,

European Journal of Cancer

2013

47

Effects of the lactase 13910 C/T and calcium-sensor receptor A986S G/T gene polymorphisms on the incidence and recurrence of colorectal cancer in Hungarian population

Krisztián Bácsi, Erika Hitre, János P. Kósa,

BMC Cancer

2008

35

The Association of Polymorphisms in 5-Fluorouracil Metabolism Genes with Outcome in Adjuvant Treatment of Colorectal Cancer

Shoaib Afzal, Milena Gusella, S⊘ren Astrup Jensen,

Pharmacogenomics

2011

32

Prognostic Significance of the Thymidylate Biosynthetic Enzymes in Human Colorectal Tumors

Judit Kralovánszky, István Köves, Zsolt Orosz,

Oncology

2002

26

Pathologic Complete Response Rates After Neoadjuvant Pertuzumab and Trastuzumab with Chemotherapy in Early Stage HER2-Positive Breast Cancer - Increasing Rates of Breast Conserving Surgery: A Real-World Experience

Katalin Boér, Zsuzsanna Kahán, László Landherr,

Pathology & Oncology Research

2021

26

High and low affinity receptors mediate growth effects of gastrin and gastrin‐Gly on DLD‐1 human colonic carcinoma cells

Shawn Ahmed, Barna Budai, Krisztina Herédi‐Szabó,

FEBS Letters

2003

24

Impact of SHMT1 polymorphism on the clinical outcome of patients with metastatic colorectal cancer treated with first-line FOLFIRI+bevacizumab

Barna Budai, Viktor Komlósi, Vilmos Adleff,

Pharmacogenetics and Genomics

2011

22

Page 1